Bristol-Myers Squibb Co. (NYSE:BMY)

The analysis of Return on Equity (ROE) reveals a period of significant volatility characterized by an initial growth phase, a severe contraction during 2024, and a subsequent robust recovery through mid-2026.

Return on Assets (ROA)

Asset efficiency demonstrated a steady upward trajectory from March 2022 (6.07%) through September 2023 (9.08%). This trend reversed sharply in 2024, with ROA falling into negative territory and reaching a trough of -9.66% by December 2024. A consistent recovery phase followed, with returns turning positive in March 2025 (5.86%) and expanding to 10.59% by June 2026.

Financial Leverage

Leverage remained relatively stable between 2.92 and 3.26 throughout 2022 and 2023. A substantial increase occurred in March 2024, where the ratio spiked to 6.01 and remained elevated above 5.40 for the remainder of the year. Beginning in 2025, a gradual deleveraging trend is observed, with the ratio declining steadily to 3.93 by June 2026.

Return on Equity (ROE) Dynamics

The fluctuations in ROE were significantly magnified by the interplay between asset returns and financial leverage. During 2022 and 2023, the combination of rising ROA and stable leverage pushed ROE from 19.79% to 28.57%. In 2024, the synchronization of negative asset returns and peak financial leverage created a compounding negative effect, resulting in a precipitous decline to -54.78% by December 2024. The subsequent rebound was driven by the restoration of positive ROA, which propelled ROE to 41.59% by June 2026, even as the company reduced its reliance on financial leverage.

An analysis of the three-component DuPont breakdown reveals a period of steady growth, followed by a severe contraction in 2024, and a subsequent strong recovery through mid-2026. The volatility in Return on Equity (ROE) is primarily driven by drastic fluctuations in Net Profit Margin and significant shifts in Financial Leverage, while Asset Turnover remained a consistent driver of efficiency.

Net Profit Margin

A positive trend was observed from March 2022 through September 2023, with margins expanding from 13.31% to 18.44%. This growth was abruptly reversed in 2024, as the company entered a period of negative profitability, reaching a trough of -18.53% in December 2024. A recovery phase began in March 2025, with margins steadily improving to reach 18.87% by June 2026, surpassing previous peak levels.

Asset Turnover

Asset utilization demonstrated a consistent and gradual upward trajectory throughout the entire period. The ratio increased from 0.46 in March 2022 to 0.56 by June 2026. This steady improvement indicates a progressive increase in the efficiency of asset deployment to generate revenue, remaining unaffected by the volatility seen in profitability and leverage.

Financial Leverage

The leverage ratio remained relatively stable between 2.92 and 3.26 from early 2022 through late 2023. A significant spike occurred in March 2024, where leverage jumped to 6.01, remaining elevated throughout the 2024 fiscal year. From March 2025 onward, a systematic reduction in leverage is observed, with the ratio declining to 3.93 by June 2026, suggesting a deleveraging strategy following the 2024 instability.

Return on Equity (ROE) Synthesis

The ROE exhibited extreme volatility, reflecting the interaction of the three DuPont components. Initial growth led to a peak of 28.57% in September 2023. The subsequent collapse in 2024, which saw ROE drop to -54.78% by December, was the result of negative net margins being amplified by a sharp increase in financial leverage. The recovery period from 2025 to 2026 saw ROE rebound aggressively, reaching 41.59% by June 2026, driven by the restoration of profit margins and sustained gains in asset turnover despite the reduction in leverage.

The return on assets (ROA) exhibits a cyclical trajectory characterized by an initial growth phase, a severe contraction during 2024, and a robust recovery through the first half of 2026. The overall performance is primarily driven by significant volatility in profitability rather than fluctuations in asset utilization.

Net Profit Margin Analysis

Profitability remained positive and generally trended upward from March 2022 through December 2023, peaking at 18.44% in September 2023. However, a sharp reversal occurred in the first quarter of 2024, with margins falling into negative territory and reaching a trough of -18.53% by December 2024. A subsequent recovery began in March 2025, with margins returning to positive values and climbing steadily to reach a period high of 18.87% by June 2026.

Asset Turnover Trends

Asset turnover demonstrates a consistent, incremental improvement throughout the entire period. Starting at 0.46 in March 2022, the ratio grew steadily, regardless of the profitability swings, to reach 0.56 by June 2026. This suggests a sustained increase in the efficiency of asset deployment to generate revenue, independent of the net income volatility.

ROA Disaggregation and Drivers

The two-component analysis reveals that the fluctuations in ROA are almost exclusively attributable to the net profit margin. While asset turnover provided a stable and improving baseline, the dramatic decline in ROA during 2024—bottoming at -9.66% in December 2024—was the direct result of the margin collapse. The recovery of ROA to 10.59% by June 2026 was fueled by the simultaneous recovery of profit margins and the continued optimization of asset turnover.